Clinical Trial Update: Genasense® (Oblimersen Sodium), Fludarabine, and Rituximab in Subjects With Chronic Lymphocytic Leukemia [Phase 1, Phase 2]

View source ↗

Summary

A completed Phase 1/Phase 2 clinical trial assessing Genasense (oblimersen sodium) in combination with fludarabine and rituximab for chronic lymphocytic leukemi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia

Drugs mentioned

• Fludarabine (Fludarabine)
• Genasense (oblimersen)
• Rituximab (rituximab)

Snippet

Sponsor: Genta Incorporated | Conditions: Chronic Lymphocytic Leukemia | Phase 1, Phase 2 | Status: COMPLETED